Assurance Infusion recalls BUP 3 mg/MORP 15 mg/mL injections in 20 mL syringes due to lack of sterility assurance. Affected lots expired by December 2019.
Lack of sterility assurance.
Assurance Infusion is recalling certain BUP 3 mg/MORP 15 mg/mL injections in 20 mL syringes because they may not be sterile. This could lead to infections if used improperly.
The syringes lack sterility assurance, meaning they might not be clean enough to prevent infections when used for injections. This could cause serious infections if the product is injected.
People who received these specific syringes from the recalled lots are affected. Those using the product for medical purposes are at risk of infection.
Check for syringes labeled with lot numbers 12162019 (expiring Dec 25, 2019) or 12102019 (expiring Dec 19, 2019). These were sold with expiration dates in December 2019.
Look for lot numbers 12162019 or 12102019 on the syringe packaging.
BUP 3 mg/MORP 15 mg/mL injections in 20 mL syringes from Assurance Infusion.
The syringes lack sterility assurance, which could lead to infections if used for injections.
Check for lot numbers 12162019 (expiring Dec 25, 2019) or 12102019 (expiring Dec 19, 2019).
We’ve drafted a message you can send Assurance Infusion to request your refund or repair — edit it as you like.
Subject: Recall D-0706-2020 — Assurance Infusion Assurance Infusion Hello, I own a Assurance Infusion that is covered by recall D-0706-2020 from Assurance Infusion. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
